Both in total population and in AF patients, no sex differences were present in ADAMTS7 promoter methylation (total population: 15.8% in males vs. 15.5% in females, p = 0.861; AF patients: 15.0% in males vs. 16.1% in females, p = 0.517). The gene discussed is ADAMTS7; the disease is atrial fibrillation.